Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
复制标题
DOI:
10.1016/j.parkreldis.2015.03.006
复制
发表时间:
2015-06
影响因子:
4.1
通讯作者:
Mash DC
中科院分区:
文献类型:
--
作者:
Goldstein DS;Sullivan P;Holmes C;Kopin IJ;Sharabi Y;Mash DC
Parkinson disease (PD) and multiple system atrophy (MSA) share some neuropathologic findings (nigrostriatal dopaminergic lesion, alpha-synuclein deposition) but not others (Lewy bodies in PD, glial cytoplasmic inclusions in MSA). In PD evidence has accrued for a vesicular storage defect and aldehyde dehydrogenase (ALDH) inhibition in residual dopaminergic terminals, resulting in accumulation of the toxic dopamine (DA) metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL). In this study we asked whether MSA entails a similar abnormal neurochemical pattern. DA and its main neuronal metabolite 3,4-dihydroxyphenylacetic acid (DOPAC), norepinephrine (NE) and its main neuronal metabolite 3,4-dihydroxyphenylglycol (DHPG), the catecholamine precursor DOPA, and DOPAL were measured in striatal and frontal cortical tissue from patients with pathologically proven end-stage MSA (N=15), sporadic PD (N=17), and control subjects (N=18). Compared to the control group, the MSA and PD groups had similarly decreased putamen DA (by 96% and 93%, p<0.0001), DOPAC (97% and 95%, p<0.0001), NE (91% and 74%, p<0.0001), and DHPG (81% and 74%, p<0.0001). In the MSA and PD groups, ratios of DOPAL:DA were 2.3 and 3.5 times control and DHPG:NE 3.1 and 2.6 times control, while DOPAC:DOPAL ratios were decreased by 61% and 74%. In both diseases cortical NE and DHPG were decreased, while DA and DOPAC were not. MSA and PD entail a catecholamine metabolic profile indicating impaired vesicular storage, decreased ALDH activity, and DOPAL buildup, which may be part of a common pathway in catecholamine neuronal death. Targeting this pathway by interfering with catecholaldehyde production or effects constitutes a novel treatment approach.
登录
查看更多内容
影响因子:
3.7
作者:
Williams, SM;Goldman-Rakic, PS
通讯作者:
Goldman-Rakic, PS
影响因子:
4.1
作者:
Rees, Jennifer N.;Florang, Virginia R.;Doorn, Jonathan A.
通讯作者:
Doorn, Jonathan A.
影响因子:
4.7
作者:
Goldstein DS;Sullivan P;Holmes C;Miller GW;Alter S;Strong R;Mash DC;Kopin IJ;Sharabi Y
通讯作者:
Sharabi Y
影响因子:
--
作者:
DelleDonne, Anthony;Klos, Kevin J.;Dickson, Dennis W.
通讯作者:
Dickson, Dennis W.
影响因子:
2.5
作者:
Wakabayashi, K;Yoshimoto, M;Takahashi, H
通讯作者:
Takahashi, H